Venetian-1 Acquisition Corp. Contracts & Agreements
25 Contracts & Agreements
- Business Finance (12 contracts)
- Business Operations (3)
- Human Resources (4)
- Intellectual Property (2)
- Mergers & Acquisitions (1)
- Uncategorized (3)
- Agreement and Plan of Merger and Reorganization among Venetian-1 Acquisition Corp, Lomond Acquisition Corp. and Lomond Therapeutics, Inc (Filed With SEC on November 7, 2024)
- Form of Placement Agent Warrant (Filed With SEC on November 7, 2024)
- Form of Simple Agreement for Future Equity, dated August 27, 2024 (Filed With SEC on November 7, 2024)
- Form of Simple Agreement for Future Equity, dated October 17, 2024 (Filed With SEC on November 7, 2024)
- Administrative Services & Co-Employment Agreement, dated October 18, 2024, by and between Abet Solutions Inc. and Lomond Therapeutics, Inc (Filed With SEC on November 7, 2024)
- Consulting Agreement with Iain Dukes, dated as of November 1, 2024 (Filed With SEC on November 7, 2024)
- Consulting Agreement with Nikolay Savchuk, dated as of November 1, 2024 (Filed With SEC on November 7, 2024)
- Form of Pre-Merger Indemnification Agreement (Filed With SEC on November 7, 2024)
- Subscription Agreement, dated November 1, 2024, by and between the Company and the parties thereto (Filed With SEC on November 7, 2024)
- Registration Rights Agreement, dated November 1, 2024, by and between the Company and the parties thereto (Filed With SEC on November 7, 2024)
- 2022 Equity Incentive Plan of Eilean Therapeutics, LLC and form of award agreements thereunder (Filed With SEC on November 7, 2024)
- Lomond Therapeutics, Inc. 2024 Stock Plan and form of award agreements thereunder (Filed With SEC on November 7, 2024)
- Lomond Therapeutics Holdings, Inc. 2024 Equity Incentive Plan and form of award agreements thereunder (Filed With SEC on November 7, 2024)
- Form of Indemnification Agreement (Filed With SEC on November 7, 2024)
- License Agreement, dated as of October 17, 2024, by and between Lomond Therapeutics, Inc. and Eil Therapeutics, Inc (Filed With SEC on November 7, 2024)
- Promissory Note, dated as of October 17, 2024, by and between Lomond Therapeutics, Inc. and Eil Therapeutics, Inc (Filed With SEC on November 7, 2024)
- License Agreement, dated as of October 17, 2024, by and between Lomond Therapeutics, Inc. and Bala Therapeutics, Inc (Filed With SEC on November 7, 2024)
- Promissory Note, dated as of October 17, 2024, by and between Lomond Therapeutics, Inc. and Bala Therapeutics, Inc (Filed With SEC on November 7, 2024)
- Promissory Note, dated as of May 2, 2022, by and between Lomond Therapeutics, Inc. and Dinas Therapeutics, Inc (Filed With SEC on November 7, 2024)
- Promissory Note, dated as of June 21, 2022, by and between Lomond Therapeutics, Inc. and Dinas Therapeutics, Inc (Filed With SEC on November 7, 2024)
- Promissory Note, dated as of December 1, 2023, by and between Lomond Therapeutics, Inc. and Eil Therapeutics, Inc (Filed With SEC on November 7, 2024)
- Promissory Note, dated as of January 5, 2023, by and between Lomond Therapeutics, Inc. and Eil Therapeutics, Inc (Filed With SEC on November 7, 2024)
- Assignment and Consent Agreement, dated as of December 7, 2023, by and among Lomond Therapeutics, Inc., Eilean Therapeutics, LLC. and Eil Therapeutics, Inc (Filed With SEC on November 7, 2024)
- Assignment and Consent Agreement, dated as of December 7, 2023, by and among Lomond Therapeutics, Inc., Eilean Therapeutics, LLC. and Dinas Therapeutics, Inc (Filed With SEC on November 7, 2024)
- Form of Lock-up Agreement entered into between the Company and the parties thereto (Filed With SEC on November 7, 2024)
